Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of sulfated heparin oligosaccharide and its preparation method and application

A technology of sulfated heparin oligosaccharide and heparin oligosaccharide, which is applied in the field of antitumor drugs, can solve the problems of difficult preparation and structure determination of N-acetylated heparin oligosaccharide, no significant improvement in heparanase activity, etc., and achieves good inhibition. Tumor metastatic activity, good heparanase inhibitory activity, small molecular weight effect

Active Publication Date: 2018-07-03
SHENZHEN HEPALINK PHARMA GRP CO LTD
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] This invention only solves the problem of difficult preparation and structure determination of heparin oligosaccharides containing N-acetylated structure, and there is no significant improvement in inhibiting the activity of heparanase in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of sulfated heparin oligosaccharide and its preparation method and application
  • A kind of sulfated heparin oligosaccharide and its preparation method and application
  • A kind of sulfated heparin oligosaccharide and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] The preparation of embodiment 1 heparin oligosaccharide

[0092] Take 24g of heparin, add 240mL of Tris-HCl buffer solution, stir to dissolve, add 480IU of heparinase I, stir evenly, and place it at 10°C for enzymolysis reaction for 16h. After the reaction was completed, the reaction mixture was heated to 95° C. for 6 min to inactivate, and ultrafiltered in a 10 KDa ultrafiltration centrifuge tube. The filtrate was separated with a Bio-Gel P-10 (2.5×100cm) chromatographic column, and 0.2M NH 4 HCO 3 As the eluent, collect 1.75-2.15 times the column volume components to obtain the heparin tetrasaccharide mixture, collect 1.35-1.75 times the column volume components to obtain the heparin hexasaccharide mixture, collect 1.05-1.35 times the column volume components to obtain the heparin 8 Sugar-sugar mixture, collect 0.85-1.05 times column volume components to get heparin decasaccharide mixture, collect 0.75-0.85 times column volume components to get heparin dodecaose mix...

Embodiment 2

[0096] Example 2 Preparation of 20%~80% Sulfated Heparin Octaose

[0097] Weigh 0.54g of heparin octasaccharide raw material, transfer it to a reaction bottle, add 25mL of anhydrous DMF, and stir to dissolve. Weigh 0.86g (CH 3 ) 3 N·SO 3 , gradually added to the above solution under stirring, and stirred for 10 min. The bottle cap was plugged, and the reaction bottle was placed in an oil bath at 80°C and stirred for 4 h. After stopping the reaction, it was naturally cooled to room temperature. The solid was dissolved in 90 mL of pure water, and the pH was adjusted to nearly neutral with 2M NaOH. The solution was transferred to a dialysis bag with a molecular weight cut-off of 100-500 Da, and after three days of dialysis, the solution was washed with BaCl 2 Check for the presence of large amounts of sulfate in the dialysate. If not, first adjust the pH to neutral with 2M NaOH, and concentrate to about 10 mL on a rotary evaporator. Put it on the P2 column, elute with pur...

Embodiment 3

[0106] Example 3 Heparanase Inhibitory Activity of 40% and 60% Sulfated Heparin Octaose

[0107] The method described in the literature [Hammond E, Li CP, Ferro V. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitorscreening. Anal. Biochem. 2011; 396: 112-116] was used to determine the concentration of sulfated heparan oligosaccharide Heparanase inhibitory activity, that is, the specific experimental operation is as follows:

[0108]The reaction solution of the experimental group was composed of 40mM sodium acetate buffer solution (pH 5.0), 100mM fondaparinux sodium, and a specific concentration of heparin sulfated octaose, and the reaction solution of the control group was composed of the same Concentration of SST0001 reference substance to replace sulfated heparin octasaccharide. Add 100 μL of the reaction solution of the experimental group or the control group to each well of the 96-well plate, and then add heparanase res...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
absorbanceaaaaaaaaaa
Login to View More

Abstract

The invention provides sulfated heparin oligosaccharide as well as a preparation method and application thereof. The sulfated heparin oligosaccharide is characterized in that a non-reducing end of a sulfated heparin oligosaccharide molecule contains an unsaturated double bond produced through enzymolysis of heparinase as well as uronic acid derivatives and glycosylamine derivatives; the sulfated heparin oligosaccharide has a structure represented by a formula I, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, Ra, Rb, Rc and Rd are independently SO3<-> or H; Rx', Ry' and Rz' are independently COCH3 or SO3<->, and n is 1-3. The sulfated heparin oligosaccharide with controllable sulfating degree prepared by virtue of the preparation method has very high activity for inhibiting heparanase in vitro, the activity of the sulfated heparin oligosaccharide for inhibiting cell adhesion and migration is 4-5 times higher than that of heparin, and the activity for inhibiting tumor metastasis in mice is 2-3 times higher than that of the heparin; the sulfated heparin oligosaccharide has relatively good tumor metastasis resistance and relatively high specificity.

Description

technical field [0001] The invention belongs to the field of antitumor drugs, and relates to a sulfated heparin oligosaccharide and a preparation method and application thereof. Background technique [0002] Tumor is a major threat to human health. More seriously, malignant tumors such as liver cancer and lung cancer are prone to metastasis. There is no drug to inhibit tumor metastasis, which makes the treatment of tumor metastasis difficult and makes tumor metastasis the most important cause of death in cancer patients. Two processes are critical for tumor cells to achieve invasion and migration: one is to break through the barrier composed of extracellular matrix (ECM) and basement membrane (BM) and the other is to form new blood vessels. ECM and BM are the barriers for tumor cell invasion and metastasis. To realize the spread and metastasis of malignant tumor cells, they must pass through the ECM and BM to enter the circulation. In this process, the degradation of variou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08B37/10C12P19/26A61K31/727A61P35/00
CPCA61K31/727C08B37/0078C12P19/00C12P19/26
Inventor 李锂马小来田方方杜媛媛杜宏银刘亚晗
Owner SHENZHEN HEPALINK PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products